6-fluoro-3-hydroxy-2-pyrazinecarboxamide,
favipiravir,
T-705 cpd,
Favipiravir,
259793-96-9,
6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDE,
T-705,
6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide,
T 705,
Favipiravir (T-705),
UNII-EW5GL2X7E0,
6-fluoro-3-hydroxy-2-pyrazinecarboxamide,
5-fluoro-2-oxo-1H-pyrazine-3-carboxamide,
Favipiravir; T-705,
EW5GL2X7E0,
Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-,
avigan,
6-fluoro-3-hydroxy-pyrazine-2-carboxamide,
2-Pyrazinecarboxamide, 6-fluoro-3-hydroxy-,
6-Fluoro-3,4-dihydro-3-oxo-2-pyrazinecarboxamide,
Favipiravir [USAN:INN:JAN],
Avigan (TN),
favipiravir-t-705,
AC1LAOUM,
T705,
SCHEMBL587913,
Favipiravir (JAN/USAN/INN),
AMPZ0004,
CHEMBL221722,
SCHEMBL15157866,
CTK8C4699,
AOB2076,
CHEBI:134722,
ZCGNOVWYSGBHAU-UHFFFAOYSA-N,
BCPP000056,
BCP02422,
EX-A2285,
ANW-72832,
BBL104098,
CF0036,
MFCD12032148,
QC-771,
RW3035,
s7975,
STL557913,
ZINC13915654,
AKOS005166863,
AKOS015995178,
ZINC584639712,
ZINC584639713,
ACN-041491,
AN-1700,
API0008132,
CS-0612,
DB12466,
FCH1143534,
PB25591,
RP22092,
AC-28900,
AK-67681,
BR-67681,
HY-14768,
SC-43861,
6-fluoro-3-oxo-4H-pyrazine-2-carboxamide,
ST1120855,
AM20080851,
FT-0686297,
FT-0701282,
A25520,
D09537,
S-7880,
793P969,
J-518718,
T 705,CAS;259793-96-9,
T 705|259793-96-9|T-705|T705,
Favipiravir [INN],
Favipiravir(T-705),
cc-562,
AIDS121660,
CID492405,
B1114,
A11590,
6-fluoro-3,4-dihydro-3-oxo-Pyrazinecarboxamide,
Pyrazinecarboxamide,6-fluoro-3,4-dihydro-3-oxo-,
5-Fluoro-2-oxo-1H-pyrazine-3-carboxamide, 95+%,
2-Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-,
N/A,